Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Acta Neurochirurgica

• Publication date

  2007-02-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00701-006-1092-yPMID 17273889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MGMT Gene Silencing and Benefit From Temozolomide in GlioblastomaHegi ME, Diserens A-C, Gorlia T, et al (Univ Hosp Lausanne, Switzerland; Univ Hosp Geneva; Swiss Inst for Experimental Cancer Research, Epalinges, Switzerland; et al) N Engl J Med 352:997–1003, 2005§

  2006cited by this paper
• Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment.

  2006cited by this paper
• Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

  2006cited by this paper
• Epidemiology and etiology of gliomas

  2005cited by this paper
• Therapy of glioblastoma multiforme: A cumulative experience of 10 years

  2005cited by this paper
• Glioblastoma multiforme-report of 267 cases treated at a single institution.

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres.

  2005cited by this paper
• Glioblastoma Multiforme in the Elderly: A Therapeutic Challenge

  2005cited by this paper
• MGMT gene silencing and benefit from temozolomide in glioblastoma.

  2005cited by this paper
• Indicators of Functional Status for Primary Malignant Brain Tumour Patients

  2005cited by this paper
• Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas

  2004cited by this paper
• A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

  2003cited by this paper
• [Glioblastomas: clinical study and search for prognostic factors].

  2002cited by this paper
• Selection of Eligible Patients with Supratentorial Glioblastoma Multiforme for Gross Total Resection

  2001cited by this paper
• A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

  2001cited by this paper
• Loss of Heterozygosity on Chromosome 10 Is More Extensive in Primary (De Novo) Than in Secondary Glioblastomas

  2000cited by this paper
• The effect of waiting for radiotherapy for grade III/IV gliomas.

  2000cited by this paper
• Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients.

  2000cited by this paper
• Primary and secondary glioblastomas: from concept to clinical diagnosis.

  1999cited by this paper
• Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.

  1999cited by this paper
• The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.

  1999cited by this paper
• Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.

  1999cited by this paper
• PTEN (MMAC1) Mutations Are Frequent in Primary Glioblastomas (de novo) but not in Secondary Glioblastomas

  1998cited by this paper
• Long-Term Survival in Cerebral Glioblastoma. Case Report and Critical Review of the Literature

  1998cited by this paper
• Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival

  1997cited by this paper
• Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.

  1995cited by this paper
• Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.

  1994cited by this paper
• Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

  1994cited by this paper
• Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs)

  1993cited by this paper
• Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

  1993cited by this paper
• The cause of death in patients with glioblastoma is multifactorial:

  1991cited by this paper
• Grading of astrocytomas: A simple and reproducible method

  1988cited by this paper
• Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

  1980cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Analysis of Patients with Glioblastoma Treated with Standard 6-Week Chemoradiation Followed by Temozolomide: Treatment Outcomes and Prognostic Factors

  2025cites this paper
• Potential Biomarkers for IDH-Mutant and IDH-Wild-Type Glioblastomas: A Single-Center Retrospective Study

  2025cites this paper
• Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumors

  2025cites this paper
• Hybrid Positron Emission Tomography and Magnetic Resonance Imaging Guided Microsurgical Management of Glial Tumors: Case Series and Review of the Literature

  2024cites this paper
• Therapy Intensity Outweighs the Prognostic Importance of the Timing of Chemoradiotherapy in Newly Diagnosed Glioblastoma Patients

  2024cites this paper
• VERY LONG-CHAIN ACYL-CoA SYNTHETASE-3 (ACSVL3) PROMOTES THE MALIGNANT GROWTH BEHAVIOR OF U87 GLIOMA CELLS VIA CHANGES IN CELL CYCLE WITHOUT AFFECTING APOPTOSIS

  2023cites this paper
• Risk factors for preoperative and postoperative seizures in patients with glioblastoma according to the 2021 World Health Organization classification.

  2023cites this paper
• What predicts survival in glioblastoma? A population-based study of changes in clinical management and outcome

  2023cites this paper
• Letter to the Editor Regarding: "Palliative Care Effects on Survival in Glioblastoma: Who Receives Palliative Care?"

  2023cites this paper
• Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial

  2023cites this paper
• Long Term Survivals in Aggressive Primary Brain Malignancies Treated With an Adjuvant Ketogenic Diet

  2022cites this paper
• The role of deep learning‐based survival model in improving survival prediction of patients with glioblastoma

  2021cites this paper
• LncRNA miR143HG inhibits the proliferation of glioblastoma cells by sponging miR-504

  2021cites this paper
• Antiseizure medication in patients with Glioblastoma- a collaborative cohort study.

  2021cites this paper
• How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis

  2021cites this paper
• The effectiveness of gamma knife radiosurgery for the management of residual high-grade gliomas: A single institutional study.

  2021cites this paper
• Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme - Data from a national neuro-oncology registry.

  2021cites this paper
• Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?

  2021cites this paper
• Five-year survival in patients with Glioblastoma is overestimated in registry data - A nationwide population-based Swedish survey during 1958 - 1999

  2021cites this paper
• Efficacy of platinum drugs in the treatment of elderly patients with advanced non-small cell lung cancer and their effects on prognosis and survival.

  2020cites this paper
• Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery.

  2020cites this paper
• Outcome prediction in brain tumor surgery: a literature review on the influence of nonmedical factors

  2020cites this paper
• Preoperative and early postoperative seizures in patients with glioblastoma—two sides of the same coin?

  2020cites this paper
• Optimization Of High-Grade Glioma Resection Using 5-Ala Fluorescence-Guided Surgery: Literature Review And Practical Recommendations From The Neuro-Oncology Club Of The French Society Of Neurosurgery.

  2019cites this paper
• Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma

  2019cites this paper
• The Gothenburg population-based glioblastoma research database: Methodological aspects and potential impact

  2019cites this paper
• Routine Blood Tests Do Not Predict Survival in Patients with Glioblastoma-Multivariable Analysis of 497 Patients.

  2019cites this paper
• Glioblastoma in Elderly Patients: Current Management and Future Perspectives

  2019cites this paper
• Review of first clinical experiences with a 1.5 Tesla ceiling-mounted moveable intraoperative MRI system in Europe.

  2019cites this paper
• Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages

  2019cites this paper
• Prognostic Factors in Glioblastoma: Is There a Role for Epilepsy?

  2018cites this paper
• Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging

  2018cites this paper
• Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival

  2018cites this paper
• Practical prognostic score for predicting the extent of resection and neurological outcome of gliomas in the sensorimotor area.

  2018cites this paper
• The Survival Effect of Repeat Surgery at Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis.

  2018cites this paper
• Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line

  2018cites this paper
• Survival of rats bearing advanced intracerebral F 98 tumors after glutathione depletion and microbeam radiation therapy: conclusions from a pilot project

  2018cites this paper
• Prognostic Value of Optimized Dynamic Contrast-Enhanced Magnetic Resonance Imaging of High-Grade Gliomas

  2018cites this paper
• Microbeam radiation therapy — grid therapy and beyond: a clinical perspective

  2017cites this paper
• Use of Preoperative Ependymal Enhancement on Magnetic Resonance Imaging Brain as a Marker of Grade of Glioma

  2017cites this paper
• Surgical Decision Making From Image‐Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime

  2017cites this paper
• Epileptic features and survival in glioblastomas presenting with seizures.

  2017cites this paper
• Effects of ACSVL3 Knockout on Lipid and Glucose Metabolism in Malignant Glioma Cells

  2016cites this paper
• Characterisation of the in vitro effects of Asiatic acid in Glioblastoma

  2016cites this paper
• Étude de nouveaux facteurs pronostiques de la survie des patients atteints de glioblastome : mutation IDH et invasivité radiologique estimée par modélisation biophysique

  2016cites this paper
• Prognostic factors for glioblastoma patients – a clinical population‐based study

  2016cites this paper
• Prognostic relevance of epilepsy at presentation in glioblastoma patients.

  2016cites this paper
• Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis

  2016cites this paper
• Role of mTOR in glioblastoma.

  2016cites this paper
• Does the choice of antiepileptic drug affect survival in glioblastoma patients?

  2016cites this paper
• Prognostic implications of epilepsy in glioblastomas.

  2015influential citation
• Prognostic factors influencing clinical outcomes of malignant glioblastoma multiforme: clinical, immunophenotypic, and fluorescence in situ hybridization findings for 1p19q in 816 chinese cases.

  2015cites this paper
• Glioblastoma in the elderly: Therapeutic dilemmas

  2015cites this paper
• Neuropathologische Untersuchungen an Gewebeproben vor und nach intraoperativem MRT bei malignen Gliomen.

  2015cites this paper
• Development of LC–MS method for analysis of paclitaxel-inhibited growth and enhanced therapeutic response in human glioblastoma cells

  2015cites this paper
• Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.

  2015cites this paper
• Characteristics of Human Cytomegalovirus specific T-Cells in Glioblastoma Multiforme

  2015cites this paper
• Correlação entre ressonância magnética, expressão do Ki-67 e p53, e prognóstico em astrocitomas

  2015cites this paper
• Awake craniotomies: Burden or benefit for the patient?

  2015cites this paper
• Glioblastoma Multiforme: A Single Hospital Experience

  2015cites this paper
• Regional skin invasion by glioblastoma multiforme

  2015cites this paper
• Nanoparticle based strategies for the treatment of Glioblastoma

  2014cites this paper
• Prognostic value of the preoperative immunological profile in patients with glioblastoma

  2014cites this paper
• An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.

  2014cites this paper
• 5-ALA fluorescence-assisted surgery in pediatric brain tumors: Report of three cases and review of the literature

  2014cites this paper
• Resection of supratentorial gliomas: the need to merge microsurgical technical cornerstones with modern functional mapping concepts. An overview

  2014cites this paper
• Frameless image-guided stereotactic brain biopsies: emphasis on diagnostic yield

  2014cites this paper
• Prognostic factors of survival in Moroccan patients with Glioblastoma

  2014influential citation
• Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010.

  2014cites this paper
• Estudio de una cohorte uruguaya de pacientes portadores de Glioblastoma tratados con radioterapia y Temozolamida Analysis of a Uruguayan cohort of patients with Glioblastoma treated with radiotherapy and Temozalamide

  2014cites this paper
• Interleukin‐17 Facilitates the Immune Suppressor Capacity of High‐Grade Glioma‐Derived CD4 (+) CD25 (+) Foxp3 (+) T Cells Via Releasing Transforming Growth Factor Beta

  2014cites this paper
• Quantification of microvascular cerebral blood flux and late‐stage tumor compartmentalization in 9L gliosarcoma using flow enhanced MRI

  2013cites this paper
• Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection?

  2013cites this paper
• Dosimetry in brain tumor phantom at 15 MV 3D conformal radiation therapy

  2013cites this paper
• Magnetic resonance diffusion tensor imaging with fluorescein sodium dyeing for surgery of gliomas in brain motor functional areas

  2013influential citation
• Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme.

  2013cites this paper
• Markers of cell division cycle in glioblastoma: significance in prediction of treatment response and patient prognosis

  2013cites this paper
• Environmental effects on molecular biomarkers expression in pancreatic and brain cancer

  2013cites this paper
• Use of medical imaging in neurorehabilitation

  2013cites this paper
• Drug resistance mechanisms in a high grade glioma cell line

  2013cites this paper
• DNA double strand breaks in the acute phase after synchrotron pencilbeam irradiation

  2013cites this paper
• Socioeconomic and educational factors interference in the prognosis for glioblastoma multiform

  2013cites this paper
• DNA double strand breaks in the acute phase after synchrotron pencilbeam irradiation

  2013cites this paper
• Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients

  2012cites this paper
• Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimen.

  2012cites this paper
• Pathological findings and prognostic factors in recurrent glioblastomas

  2012cites this paper
• Elderly Patients Affected by Glioblastoma Treated With Radiotherapy: The Role of Serum Hemoglobin Level

  2012cites this paper
• Gross Total Resection of Glioma with the Intraoperative Fluorescence-guidance of Fluorescein Sodium

  2012cites this paper
• Effects of Socioeconomic on Survival for Adult Glioblastoma Multiform Patients in Rio de Janeiro, Brazil, 1999-2009

  2012cites this paper
• The prognostic value of perfusion MRI in cerebral glioma

  2012cites this paper
• The impact of enrollment in clinical trials on survival of patients with glioblastoma.

  2012cites this paper
• Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review).

  2012cites this paper
• Development of FENSI (Flow Enhanced Signal Intensity) perfusion sequence and application to the characterization of microvascular flow dynamics using MRI

  2012cites this paper
• Surgical extent impacts the value of the established prognosticators in glioblastoma patients: A prospective translational study in Asia

  2012cites this paper
• Trends in classification, referral and treatment and the effect on outcome of patients with glioma: a 20 year cohort

  2011influential citation
• Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide

  2011cites this paper
• Mitochondrial DNA depletion and its correlation with TFAM, TFB1M, TFB2M and POLG in human diffusely infiltrating astrocytomas.

  2011cites this paper
• Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.

  2011cites this paper
• Relationship between CacyBP/SIP expression and prognosis in astrocytoma.

  2011cites this paper
• Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy

  2010cites this paper